Vasomotor symptoms in menopausal women linked to greater risk for non-alcoholic fatty liver disease

FHS
June 3, 2024
5:45 pm

Women experiencing moderate-to-severe vasomotor symptoms face a three times greater risk for metabolic-dysfunction-associated steatotic liver disease (MASLD) compared to those with mild symptom severity, according to research being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Robotics Companies & Solutions for the Pharmaceutical Industry

Robotics companies are playing an increasingly pivotal role within the pharmaceutical industry. Robotic automation companies are vastly increasing the capability of modern pharmaceutical businesses. For

October 1, 2024

A comprehensive global and regional analysis of human Brucellosis incidence

An evidence-based estimation of global and regional human Brucellosis incidence.

August 23, 2023

Microwave Ablation a Safer Option for Multifocal Papillary Thyroid Carcinoma?

The use of microwave ablation to treat ultrasound-detected, multifocal papillary thyroid carcinoma (PTC) was associated with the same outcomes but fewer complications compared with surgical

April 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.